You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

childhood acute myeloblastic leukemia with maturation (M2)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b) Trial

Completed
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +13 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Feb 2, 2023

Childhood Acute Basophilic Leukemia, Childhood Acute Eosinophilic Leukemia, Childhood Acute Erythroleukemia (M6) Trial in

Completed
Has Results
  • Childhood Acute Basophilic Leukemia
  • +14 more
  • Phoenix, Arizona
  • +96 more
Jan 20, 2022

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

Completed
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +15 more
  • trebananib
  • +3 more
  • Buffalo, New York
  • +1 more
Sep 8, 2022

Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7) Trial in Atlanta,

Terminated
  • Adult Acute Basophilic Leukemia
  • +16 more
  • eltrombopag olamine
  • standard follow-up care
  • Atlanta, Georgia
  • +1 more
Jul 20, 2022

Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Basophilic Leukemia, Adult

Active, not recruiting
Has Results
  • Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
  • +18 more
  • eltrombopag olamine
  • Cleveland, Ohio
    Case Comprehensive Cancer Center
Nov 29, 2021

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

Terminated
Has Results
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +15 more
  • fludarabine phosphate
  • +4 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Aug 20, 2021

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

Completed
Has Results
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +16 more
  • choline magnesium trisalicylate
  • +3 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Aug 20, 2021

CBFA2T3-GLIS2-positive Acute Myeloid Leukemia, AML, Childhood, Relapsed Pediatric AML Trial (ELU001)

Not yet recruiting
  • CBFA2T3-GLIS2-positive Acute Myeloid Leukemia
  • +3 more
  • (no location specified)
Nov 14, 2022

Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in

Suspended
  • Juvenile Myelomonocytic Leukemia
  • +27 more
  • CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 11, 2023

Patients With Acute Leukemia Infected by COVID-19

Completed
  • Acute Myeloblastic Leukemia
  • +2 more
    • Amiens, France
    • +26 more
    Jul 26, 2022

    Acute Undifferentiated Leukemia, B-cell Adult Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia Trial

    Completed
    Has Results
    • Acute Undifferentiated Leukemia
    • +13 more
    • Chicago, Illinois
      Cancer and Leukemia Group B
    Apr 5, 2022

    Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7) Trial in United

    Completed
    Has Results
    • Adult Acute Basophilic Leukemia
    • +16 more
    • Little Rock, Arkansas
    • +53 more
    Jan 13, 2022

    Acute Myeloid Leukemia, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia Trial in Houston (Decitabine, Quizartinib,

    Recruiting
    • Acute Myeloid Leukemia
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 27, 2023

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome

    Active, not recruiting
    • Acute Lymphoblastic Leukemia
    • +15 more
    • Laboratory Biomarker Analysis
    • +3 more
    • Chicago, Illinois
    • +2 more
    Jan 12, 2023

    Relapsed Adult AML, Refractory AML Trial in Milwaukee (Navitoclax Dose Level -1, Navitoclax Dose Level 0, Navitoclax Dose Level

    Not yet recruiting
    • Relapsed Adult AML
    • Refractory AML
    • Navitoclax Dose Level -1
    • +10 more
    • Milwaukee, Wisconsin
      Froedtert Hospital & the Medical College of Wisconsin
    Aug 17, 2023

    Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in

    Recruiting
    • Acute Biphenotypic Leukemia
    • +13 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 19, 2023

    Hematopoietic and Lymphoid Cell Tumor, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Myeloid Leukemia Trial in Houston

    Recruiting
    • Hematopoietic and Lymphoid Cell Neoplasm
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 31, 2022

    High Risk Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston

    Completed
    • High Risk Myelodysplastic Syndrome
    • +2 more
    • Daratumumab
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 21, 2022

    Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Mixed Phenotype Acute Leukemia Trial in Seattle (Cladribine, Cytarabine,

    Recruiting
    • Acute Biphenotypic Leukemia
    • +11 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Oct 18, 2022

    Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood B-Lymphoblastic Lymphoma Trial in San Diego,

    Completed
    Has Results
    • Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia
    • Recurrent Childhood B-Lymphoblastic Lymphoma
    • San Diego, California
    • +2 more
    Sep 13, 2022

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous

    Recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 31, 2022

    Acute Myeloid Leukemia, Blasts 20 Percent or More of Bone Marrow Nucleated Cells, High Risk Myelodysplastic Syndrome Trial in

    Recruiting
    • Acute Myeloid Leukemia
    • +7 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 7, 2022

    ALL, Childhood, Lymphoblastic Lymphoma, Childhood, Lymphoblastic Leukemia, Acute, Childhood Trial in Australia, United States

    Recruiting
    • ALL, Childhood
    • +2 more
    • Los Angeles, California
    • +17 more
    Aug 11, 2022

    BD OneFlow Acute Leukemia Panel on BD FACSLyric Flow Cytometer

    Recruiting
    • Acute Leukemia
    • IUO Acute Leukemia Panel
    • Los Angeles, California
    • +6 more
    Jul 15, 2022

    Leukemia, Myeloid, Acute, MDS Trial in Japan, Korea, Republic of, Taiwan (Pevonedistat 25 mg/m^2, Pevonedistat 44 mg/m^2,

    Completed
    • Leukemia, Myeloid, Acute
    • Myelodysplastic Syndromes
    • Pevonedistat 25 mg/m^2
    • +4 more
    • Maebashi City, Japan
    • +8 more
    Jun 23, 2022